Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy

NCT04055090 is registered in ClinicalTrials.gov with Helixmith Co., Ltd. as lead sponsor.

NCT NCT04055090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04055090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Lead sponsor
Helixmith Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
February 4, 2019
Completion date
July 24, 2019
Enrollment
101 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy, painful, painful diabetic neuropathy